<DOC>
	<DOCNO>NCT01195090</DOCNO>
	<brief_summary>This 24-weeks study compare glycemic efficacy safety sitagliptin pioglitazone patient type 2 diabetes inadequate glycemic control despite dual therapy metformin sulfonylurea .</brief_summary>
	<brief_title>Adding Sitagliptin Pioglitazone Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Sulfonylurea</brief_title>
	<detailed_description>This prospective , open-label , randomize , parallel , 24-week study . Inclusion criterion : type 2 diabetes patient treat stable dos sulfonylurea metformin half maximally dose ( sulfonylureas &gt; half maximal dose , metformin &gt; 1500 mg/d ) &gt; 10 week . &gt; 20 year old ; A1C : &gt; 7.0 % &lt; 11 % Exclusion criterion : insulin use within 12 week screen visit , contraindication use sitagliptin pioglitazone , impaired renal function ( serum creatinine &gt; 1.4 mg/dl ) , alanine aminotransferase ( ALT ) aspartate aminotransferase level ( AST ) &gt; 2.5 time upper limit normal ( ULN ) , current prepare pregnancy lactation . Primary Purpose : compare change hemoglobin A1c proportion patient achieve A1C &lt; 7 % 2 group Secondary Purposes : 1 . Changes fast plasma glucose , high sensitive C-reactive protein ( hsCRP ) 2 . Homeostasis model assessment-β cell function ( HOMA-β ) calculate assess change β-cell function HOMA-insulin resistance ( HOMA-IR ) ass change insulin resistance 3 . Body weight change , proportion side effect</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Type 2 diabetes patient treat stable dos sulfonylurea metformin half maximally dose ( sulfonylureas &gt; half maximal dose , metformin &gt; 1500 mg/d ) &gt; 10 week &gt; 20 year old A1C : &gt; 7.0 % &lt; 11 % Insulin use within 12 week screen visit Any contraindication use sitagliptin pioglitazone , impaired renal function ( serum creatinine &gt; 1.4 mg/dl ) , alanine aminotransferase aspartate aminotransferase level &gt; 2.5 time upper limit normal Current prepare pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>sitagliptin</keyword>
	<keyword>pioglitazone</keyword>
	<keyword>type 2 diabetes</keyword>
</DOC>